Survival after brain metastases in Asian patients with HER2+breast cancer

被引：4
|
作者：
Yap, Y. S.
Devi, B. C.
Khorprasert, C.
Cornelio, G. H.
Sutandyo, N.
Yeoh, E.
Landis, S.
Kobayashi, M.
Moon, H.
Ro, J.
机构：
[1] Natl Canc Ctr, Singapore, Singapore
[2] Sarawak Gen Hosp, Sarawak, Malaysia
[3] Chulalongkorn Univ, Bangkok 10330, Thailand
[4] San Juan Dios Hosp, Pasay City, Philippines
[5] Darmais Canc Ctr Hosp, Jakarta, Indonesia
[6] GlaxoSmithKline, Singapore, Singapore
[7] GlaxoSmithKline, Stockley Pk, England
[8] GlaxoSmithKline, Res Triangle Pk, NC USA
[9] GlaxoSmithKline Pte Ltd, Seoul, South Korea
[10] Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
543
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CLINICOPATHOLOGICAL EVALUATION OF BRAIN METASTASES RECURRENCE IN METASTATIC HER2+BREAST CANCER PATIENTS
    Gasol Cudos, Ariadna
    Morales Murillo, Serafin
    Velasco Sanchez, Ana
    Serrate Lopez, Ana
    Aguirre Ortega, Elena
    Panades Siurana, Maria Jose
    Salud Salvia, Antonieta
    BREAST, 2013, 22 : S51 - S51
  • [2] RAD51 and brain metastases (BM) in patients (pts) with HER2+breast cancer
    Duchnowska, R.
    Jassem, J.
    Szutowicz, E.
    Biernat, W.
    Jankowski, T.
    Och, W.
    Staszkiewicz, R.
    Chudzik, M.
    Rogowski, W.
    Flores, N.
    Woditschka, S.
    Li, L.
    Goswami, C.
    Thorat, M. A.
    Gokmen-Polar, Y.
    Sledge, G. W.
    Steeg, P. S.
    Palmieri, D.
    Badve, S. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Phase II trial of lapatinib for brain metastases in patients with HER2+breast cancer.
    Lin, N. U.
    Carey, L. A.
    Liu, M. C.
    Younger, J.
    Come, S. E.
    Bullitt, E.
    Van den Abbeele, A. D.
    Li, X.
    Hochberg, F. H.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 3S - 3S
  • [4] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Yap, Y. S.
    Cornelio, G. H.
    Devi, B. C. R.
    Khorprasert, C.
    Kim, S. B.
    Kim, T. Y.
    Lee, S. C.
    Park, Y. H.
    Sohn, J. H.
    Sutandyo, N.
    Wong, D. W. Y.
    Kobayashi, M.
    Landis, S. H.
    Yeoh, E. M.
    Moon, H.
    Ro, J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1075 - 1082
  • [5] Evolving management of HER2+breast cancer brain metastases and leptomeningeal disease
    Mills, Matthew N.
    King, Whitney
    Soyano, Aixa
    Pina, Yolanda
    Czerniecki, Brian J.
    Forsyth, Peter A.
    Soliman, Hatem
    Han, Hyo S.
    Ahmed, Kamran A.
    JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (02) : 249 - 269
  • [6] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Y S Yap
    G H Cornelio
    B C R Devi
    C Khorprasert
    S B Kim
    T Y Kim
    S C Lee
    Y H Park
    J H Sohn
    N Sutandyo
    D W Y Wong
    M Kobayashi
    S H Landis
    E M Yeoh
    H Moon
    J Ro
    British Journal of Cancer, 2012, 107 : 1075 - 1082
  • [7] Targeting HER2+Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies
    Chiec, Lauren
    Kumthekar, Priya
    CNS DRUGS, 2022, 36 (02) : 167 - 179
  • [8] Impact of Hormone Receptor Status on Development of Brain Metastases from HER2+Breast Cancer
    Sachar, S.
    Chen, E.
    Harris, E. E.
    Montero, A. J.
    Choi, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E62 - E63
  • [9] HER-2 overexpression does not decrease survival of breast cancer patients with brain metastases
    Krzemieniecki, K.
    Pluta, E.
    EJC SUPPLEMENTS, 2008, 6 (07): : 183 - 183
  • [10] HER2+breast cancer
    Hicks, David G.
    Kulkarni, Swati
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (02) : 263 - 273
12345